Concourse Financial Group Securities’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-897
Closed -$49.6K 888
2024
Q4
$49.6K Sell
897
-101
-10% -$5.18K ﹤0.01% 1225
2024
Q3
$57.1K Buy
998
+985
+7,577% +$56.5K ﹤0.01% 1137
2024
Q2
$680 Hold
13
﹤0.01% 2168
2024
Q1
$528 Hold
13
﹤0.01% 2208
2023
Q4
$480 Buy
+13
New +$490 ﹤0.01% 2185
2023
Q2
Sell
-24
Closed -$819 2388
2023
Q1
$916 Buy
+24
New +$1.13K ﹤0.01% 2178
2021
Q1
Sell
-181
Closed -$8.26K 2372
2020
Q4
$8K Buy
+181
New +$6.51K ﹤0.01% 1750
2019
Q1
Sell
-500
Closed -$8.1K 2319
2018
Q4
$7K Buy
+500
New +$7.98K ﹤0.01% 1528

Other funds holding HALO

Concourse Financial Group Securities's HALO Position: Q1 2025 in Review

Concourse Financial Group Securities sold out of Halozyme (HALO) in Q1 2025, closing a stake of 897 shares — an estimated $49.6K sold.

Concourse Financial Group Securities first reported a position in HALO in Q4 2018 and held it in 8 quarters. The position peaked at $57.1K in Q3 2024. 550 funds tracked by Wall St. Rank hold HALO as of Q1 2025.

  • Concourse Financial Group Securities reported no remaining Halozyme position as of Q1 2025 after selling out during the quarter.
  • Concourse Financial Group Securities sold 897 Halozyme shares in Q1 2025, an estimated $49.6K.
  • Concourse Financial Group Securities first reported a position in Halozyme in Q4 2018 and held it in 8 quarters.
  • Concourse Financial Group Securities's Halozyme position peaked at $57.1K in Q3 2024.
  • 550 funds tracked by Wall St. Rank held Halozyme as of Q1 2025.

Based on Concourse Financial Group Securities's 13F filing for Q1 2025.